Live-attenuated bacteria as a cancer vaccine vector. - Wikidata - wikimedia - TriplyDB

Live-attenuated bacteria as a cancer vaccine vector.

Live-attenuated bacteria as a cancer vaccine vector.

http://www.wikidata.org/entity/Q38152473

about

Vaccines for the 21st century Improving cell-based therapies by nanomodification Gene therapy for cancer: regulatory considerations for approval Classification of current anticancer immunotherapies The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells RNA-seq Brings New Insights to the Intra-Macrophage Transcriptome of Salmonella Typhimurium Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma.Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis.Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors.Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.Recent advances in Toxoplasma gondii immunotherapeutics.Intracellular delivery of biologic therapeutics by bacterial secretion systems.An orally administered DNA vaccine targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth.Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.New developments in cancer vaccines.Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.The dawn of vaccines for cancer prevention.

P2860

Q27007529-8BC178B8-366E-44F3-AC51-E7D70334075B Q28080427-9108053E-6903-4545-8AB2-E0063F3198BD Q28086805-64A63282-CDB1-4197-98D2-0FA43F300534 Q35149637-99CC517A-287B-4004-9E29-399A17D8D706 Q35832233-E1F86D9C-DD4B-4E76-B6D0-7E60B6BB2EB0 Q35839664-201F6A6B-87FB-4EE4-9544-D72C0D972DC0 Q35984126-29F15E53-A937-4508-80ED-A0621DC085E2 Q36865803-EA8C3546-EE11-4B72-BCEB-58F71E9864F0 Q37228973-D413D4EB-1A48-409E-BF95-BA8CCAD61E4B Q37502444-F632DC5E-2FA9-466E-BB5F-14E2687C9C27 Q38303517-6EBA0F47-9F37-49BC-909A-1B5A0F5F6323 Q38734240-C82D6466-DDB0-457D-9BF7-65BF2C564212 Q38834918-B7B60A53-BD5F-46E2-8BF6-7F8477B648EE Q40068135-CFD9D794-AD60-4A7B-AC25-FD889FAA8C78 Q43135801-482492CB-467E-4937-8AD1-65701778BA13 Q46502445-FFCEA159-B31B-4851-9D23-459DDD72507E Q47559036-7C677632-118B-43E9-94D6-80423A799EE0 Q49566629-983210E2-60A8-40B3-8F05-4852A637A64D

P2860

Live-attenuated bacteria as a cancer vaccine vector.

http://www.wikidata.org/entity/Q38152473

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Live-attenuated bacteria as a cancer vaccine vector.

@en

type

label

Live-attenuated bacteria as a cancer vaccine vector.

@en

prefLabel

Live-attenuated bacteria as a cancer vaccine vector.

@en

P1433

Q38152473-9531C88B-D505-4EAD-91A0-3E42A26C6DF9

P1476

Q38152473-077752DF-5499-4ABE-ACB2-65F71286CD56

P2093

Q38152473-598F621E-73FB-418A-8DE6-ACC3F18751C4

Q38152473-A2038619-4C01-4833-BA2E-1533503C5EEC

Q38152473-AF335D4C-AD35-4868-9611-514CF8E3A5DF

Q38152473-D1401274-CDD4-4202-8655-15266B2B2815

Q38152473-FD2E4654-54D7-4D3C-A714-6A767667DC6B

P2860

Q38152473-001C4352-EC77-4CF2-850E-84221BCF28E8

Q38152473-00993DE1-865D-4586-B66E-D0CAE0176656

Q38152473-0325E9B3-22EF-4F09-A920-636F11F5A978

Q38152473-03E83A65-08B7-4429-A88F-CE694A44614C

Q38152473-057EF769-FBD9-4A38-B919-31B1CFAA2D81

Q38152473-075E3D7F-CAAF-4B3E-A08B-F29E4E89721F

Q38152473-0A1CE28F-3CCE-4B2F-8CF5-8B0FDB9A89BC

Q38152473-107FF431-8DE4-480D-AF30-70F667597145

Q38152473-14C011BD-7A16-4E79-BDFF-4AE71473CC01

Q38152473-19066435-3FAF-4A7A-9A9E-56F126432926

P304

Q38152473-40E64457-BF53-4595-BC11-2C949E651A50

P31

Q38152473-BD9C73B1-9322-49EF-9125-4EE4CC31E608

P356

Q38152473-4AD0307F-DF12-487A-AF5A-A0D4123007D8

P433

Q38152473-DCCC4C74-473F-40F4-9F07-1F118CA08C8D

P478

Q38152473-D4AED592-AF23-44D6-A6A1-4AC6ABD9C489

P50

Q38152473-A5005E91-6228-4572-A112-2C695108372B

P577

Q38152473-236C5BDF-E5A3-47BE-95F8-ED0D6B623813

P5875

Q38152473-0214B1B0-C98E-4C65-BCF3-CC8FEE060D34

P698

Q38152473-9F8E7FA0-F89B-4046-9945-24409AE4E18E

P921

Q38152473-A4DA2943-73FA-437B-8443-E47DF23DC511

P356

14760584.2013.836914

P1433

Expert Review of Vaccines

P1476

Live-attenuated bacteria as a cancer vaccine vector.

@en

P2093

Audrey Le Gouëllec

http://www.w3.org/2001/XMLSchema#string

Benoit Polack

http://www.w3.org/2001/XMLSchema#string

Bertrand Toussaint

http://www.w3.org/2001/XMLSchema#string

Xavier Chauchet

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

Protein delivery into eukaryotic cells by type III secretion machines

Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Oral delivery of the Sj23LHD-GST antigen by Salmonella typhimurium type III secretion system protects against Schistosoma japonicum infection in mice.

Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions.

Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.

CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma

A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines.

Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.

Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature

P304

1139-1154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2013.836914

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Audrey Le Gouëllec

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257812714

http://www.w3.org/2001/XMLSchema#string

P698

24124876

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine